InvestorsHub Logo
Followers 166
Posts 36223
Boards Moderated 6
Alias Born 10/20/2019

Re: budfoxfun post# 2678

Tuesday, 04/18/2023 2:49:35 PM

Tuesday, April 18, 2023 2:49:35 PM

Post# of 2792
Power Hour approaches and we'll see if this can break 0.058.

$NBIO - About Nascent Biotech

Nascent Biotech, Inc. is a clinical-stage biotech company pioneering the development of monoclonal antibodies to be used in the treatment of various cancers and viral infections, helping people worldwide. Its products are not yet commercially available. The Company's lead candidate, Pritumumab (PTB), is a monoclonal Antibody (Mab) that is being studied in Phase I clinical trials for the treatment of Brain Cancer.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NBIO News